Disclosures for "Novel Stop-gain SORL1 Mutation in a Peruvian Family with Alzheimer's Disease of the PeADI Study"
-
The institution of Dr. Cornejo Olivas has received research support from CONCYTEC-PROCIENCIA PERU. Dr. Cornejo Olivas has a non-compensated relationship as a Board member at Rare Disorders Burou (CCI-MINSA) with Ministry of Health in Peru that is relevant to AAN interests or activities.
-
Dr. Griswold has received research support from National Institutes of Health.
-
Ms. Saldarriaga-Mayo has nothing to disclose.
-
Dr. Mena has nothing to disclose.
-
Dr. Rodriguez has nothing to disclose.
-
Larry D. Adams has nothing to disclose.
-
Patrice Whitehead has nothing to disclose.
-
The institution of Prof. Isasi has received research support from NIH.
-
Dr. Illanes-Manrique has nothing to disclose.
-
Dr. Sarapura-Castro has nothing to disclose.
-
Farid Rajabli has nothing to disclose.
-
-
-
Miss Manrique Enciso has nothing to disclose.
-
The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH.
-
The institution of Dr. Suarez has received research support from Alzheimer's Association.
-
Dr. St George-Hyslop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TransitionBio. The institution of Dr. St George-Hyslop has received research support from NIH. Dr. St George-Hyslop has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Araujo-Aliaga has nothing to disclose.
-
Michael L. Cuccaro has nothing to disclose.
-
Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
-
Dr. Pericak-Vance has nothing to disclose.